Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

• Piero L. Olliaro ,

  * E-mail: piero.olliaro@ndm.ox.ac.uk

  Affiliations UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization (WHO), Geneva, Switzerland, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Annette C. Kuesel,

  Affiliation UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization (WHO), Geneva, Switzerland

  ⨯
• Christine M. Halleux,

  Affiliation UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization (WHO), Geneva, Switzerland

  ⨯
• Mark Sullivan,

  Affiliation Medicines Development for Global Health (MDGH), Melbourne, Australia

  http://orcid.org/0000-0003-3049-1034

  ⨯
• John C. Reeder

  Affiliation UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization (WHO), Geneva, Switzerland

  ⨯